Adjuvant Pelvic Radiation Therapy±Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma
Adenocarcinoma, Clear Cell
Neoplasms, Cystic, Mucinous, and Serous
The addition of brachytherapy to adjuvant EBRT in stages I-II UPSC, CC, and HGE cancer did not demonstrate superior CSS. Thus, patients may not benefit from the addition of brachytherapy to EBRT.
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency